[go: up one dir, main page]

DK478989A - 1,4-DIHYDROPYRIDINE DERIVATIVE, PROCEDURES FOR ITS PREPARATION AND PHARMACEUTICAL AGENTS CONTAINING IT - Google Patents

1,4-DIHYDROPYRIDINE DERIVATIVE, PROCEDURES FOR ITS PREPARATION AND PHARMACEUTICAL AGENTS CONTAINING IT Download PDF

Info

Publication number
DK478989A
DK478989A DK478989A DK478989A DK478989A DK 478989 A DK478989 A DK 478989A DK 478989 A DK478989 A DK 478989A DK 478989 A DK478989 A DK 478989A DK 478989 A DK478989 A DK 478989A
Authority
DK
Denmark
Prior art keywords
procedures
preparation
pharmaceutical agents
agents containing
dihydropyridine derivative
Prior art date
Application number
DK478989A
Other languages
Danish (da)
Other versions
DK478989D0 (en
Inventor
Jean-Louis Peglion
Yves-Michel Gargouil
Jean-Paul Vilaine
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of DK478989D0 publication Critical patent/DK478989D0/en
Publication of DK478989A publication Critical patent/DK478989A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

(-)2{[2-(2-Aminoethoxy)ethoxy]methyl}-4-(2,3-dichlorophenyl)-3-etho xycarbonyl-5-methoxycarbonyl-6-methyl-1,4-dihydropyridine compound of formula I <IMAGE> and its addition salts with a pharmaceutically acceptable inorganic or organic acid. Medication.
DK478989A 1989-07-04 1989-09-28 1,4-DIHYDROPYRIDINE DERIVATIVE, PROCEDURES FOR ITS PREPARATION AND PHARMACEUTICAL AGENTS CONTAINING IT DK478989A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8908920A FR2649395B1 (en) 1989-07-04 1989-07-04 NEW DERIVATIVE OF 1,4-DIHYDRO PYRIDINE NAMED (-) I1(((2-AMINO ETHOXY)-2 ETHOXY) METHYLI1) -2 (2,3-DICHLORO-PHENYL)-4 ETHOXYCARBONYL-3 METHOXYCARBONYL -5 METHYL-6 DIHYDRO-1,4 PYRIDINE, ITS PREPARATION PROCESS AND THE COMPOSITIONS WHICH CONTAIN IT

Publications (2)

Publication Number Publication Date
DK478989D0 DK478989D0 (en) 1989-09-28
DK478989A true DK478989A (en) 1991-01-05

Family

ID=9383413

Family Applications (1)

Application Number Title Priority Date Filing Date
DK478989A DK478989A (en) 1989-07-04 1989-09-28 1,4-DIHYDROPYRIDINE DERIVATIVE, PROCEDURES FOR ITS PREPARATION AND PHARMACEUTICAL AGENTS CONTAINING IT

Country Status (14)

Country Link
EP (1) EP0406502B1 (en)
JP (1) JPH0720934B2 (en)
AT (1) ATE122340T1 (en)
AU (1) AU619049B2 (en)
CA (1) CA1327582C (en)
DE (1) DE68922605T2 (en)
DK (1) DK478989A (en)
ES (1) ES2074472T3 (en)
FR (1) FR2649395B1 (en)
IE (1) IE67059B1 (en)
NZ (1) NZ230854A (en)
OA (1) OA09136A (en)
PT (1) PT91869B (en)
ZA (1) ZA897349B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2652083B1 (en) * 1989-09-20 1992-01-24 Ador Cie NOVEL PROCESS FOR SEPARATING OPTICAL ISOMERS OF 1,4-DIHYDRO PYRIDINE DERIVATIVES.
FR2686879B1 (en) * 1992-02-05 1994-03-18 Adir Cie NOVEL 1,4-DIHYDROPYRIDINE COMPOUNDS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
DE4444864A1 (en) * 1994-12-16 1996-06-20 Bayer Ag Use of 5-acyl-1,4-dihydropyridines

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK161312C (en) * 1982-03-11 1991-12-09 Pfizer CHANGES FOR THE PREPARATION FOR THE PREPARATION OF 2-Amino-CO-Methyl-4-Methyl-4-Methyl-4-Methyl-4-Methyl-4-Methyl-4-Methyl-2-D-Hydroxy
FR2602231B1 (en) * 1986-08-04 1988-10-28 Adir NOVEL 1,4-DIHYDRO PYRIDINE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Also Published As

Publication number Publication date
ZA897349B (en) 1990-09-26
JPH0720934B2 (en) 1995-03-08
DK478989D0 (en) 1989-09-28
AU4239089A (en) 1991-01-10
CA1327582C (en) 1994-03-08
NZ230854A (en) 1991-02-26
EP0406502B1 (en) 1995-05-10
PT91869A (en) 1991-03-20
PT91869B (en) 1995-07-18
FR2649395A1 (en) 1991-01-11
IE893103A1 (en) 1991-01-16
DE68922605D1 (en) 1995-06-14
JPH0344371A (en) 1991-02-26
DE68922605T2 (en) 1996-01-04
OA09136A (en) 1991-10-31
EP0406502A1 (en) 1991-01-09
ES2074472T3 (en) 1995-09-16
ATE122340T1 (en) 1995-05-15
FR2649395B1 (en) 1992-11-06
AU619049B2 (en) 1992-01-16
IE67059B1 (en) 1996-02-21

Similar Documents

Publication Publication Date Title
NO891698L (en) PYRIDON CARBOXYLIC ACID DERIVATIVES AND PROCEDURE FOR THEIR PREPARATION.
PT102145A (en) PETERAZINE ACETAMIDE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS.
ES2056860T3 (en) DERIVATIVES OF N - ((2-OXOPYROLIDIN-1-IL) -ACETYL) PIPERAZINE AND MEDICATION AGAINST SENILE DEMENTIA.
MX9200777A (en) 4 - [(2-BENZOTIAZOLYL) METHYLAMINE] -ALPHA - [(3,4-DIFLUOROFENOXI) METHYL] -1-PIP ERIDETHANOL.
DK478989A (en) 1,4-DIHYDROPYRIDINE DERIVATIVE, PROCEDURES FOR ITS PREPARATION AND PHARMACEUTICAL AGENTS CONTAINING IT
DK0421297T3 (en) Injectable preparations containing cephalosporin as a drug and its use
EP0535250A4 (en) Novel compounds and use thereof as medicine
NO985202D0 (en) Anti-heliobacter pylori preparations containing 1-methylcarbapenem derivatives
PT855398E (en) SASQUITERPENE DERIVATIVES HAVING ANTIVIRAL ACTIVITY
ATE154243T1 (en) BLOOD VESSEL HYPERTROPHY INHIBITOR

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment